Clinicopathological analysis and risk factors of advanced colorectal neoplasms incidentally detected by 18F-FDG PET-CT

SM Chung, KO Kim, IH Cho, TN Kim - European Journal of …, 2017 - journals.lww.com
Background As the clinical use of fluorine-18-fluorodeoxyglucose PET-computed
tomography (18 F-FDG PET-CT) has increased, the incidental finding of 18 F-FDG uptake …

[HTML][HTML] Diagnostic Performance of Rectal CT for Staging Rectal Cancer: Comparison with Rectal MRI and Histopathology

SY Son, YS Seo, JH Yoon, BY Hur… - Journal of the Korean …, 2023 - ncbi.nlm.nih.gov
Purpose To compare the diagnostic performance of rectal CT with that of high-resolution
rectal MRI and histopathology in assessing rectal cancer. Materials and Methods Sixty …

[PDF][PDF] Construct validity Indonesian version of Barthel index for post stroke

J Lorica, S Rosdewi, M Solon - Indian Journal of Public Health, 2020 - core.ac.uk
Abstract Background & Aims: Stroke is a significant health problem with high prevalence and
mortality worldwide. In Indonesia, it is the first leading cause of death after ischemic heart …

Impact of Tumor Location on Survival in Patients With Colorectal Cancer: A Retrospective Cohort Study Based on Taiwan's Cancer Registry Database

SC Yu, KM Liao, CL Chou, YF Tian… - Clinical Medicine …, 2022 - journals.sagepub.com
Background: Colorectal cancer is one of the leading cancers worldwide. This study aimed to
investigate the mortality differences between 2 primary tumor locations, the proximal/distal …

The use of dostarlimab, a safe and efficient monotherapy in MSI-H rectal cancer patients, an alternative to surgery

Y Baz, M Rassam, E Rhayem, J Zouein, J Gharios… - …, 2023 - Taylor & Francis
Rectal cancer (RC) represents approximately 30% of all colorectal cancers (CRC).
Diagnosis and treatment of RC have witnessed important progress over the years [1] …

[HTML][HTML] Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer

R Carter, A Cheraghchi-Bashi… - Cancer Biology & …, 2019 - ncbi.nlm.nih.gov
Objective Patients with BRAF-mutant colorectal cancer (CRC) have a poor prognosis.
Molecular status is not currently used to select which drug to use in combination with …

[PDF][PDF] CARCINOMA DE RECTO ESTUDIO, ESTADIFICACIÓN CLÍNICA Y PLANIFICACIÓN DEL TRATAMIENTO.

C Vaccaro, N Peralta, M González - Clínicas Quirúrgicas del Cáncer …, 2020 - sacd.org.ar
El manejo del cáncer de recto es un paradigma del manejo multidisciplinario. Los nuevos
desarrollos en la técnica quirúrgica, los avances de los métodos por imágenes y los …

Эпидемиологический и социальноповеденческий портрет больного колоректальным раком в Тюменской области

НМ Фёдоров, ПБ Зотов, ЕБ Подгалъная… - Научный форум …, 2018 - elibrary.ru
Цель исследования: определить место колоректального рака в структуре
заболеваемости пациентов Тюменской области и составить социальноповеденческий …

Blood bacterial DNA, intestinal adenoma and colorectal cancer

M Mutignani, R Penagini, G Gargari, S Guglielmetti… - medRxiv, 2021 - medrxiv.org
Objective We aimed to investigate the relation of blood bacterial DNA load and profiling with
intestinal adenoma (IA) and colorectal cancer (CRC) patients. Design We performed 16S …

Lymph Nodes With Germinal Centers Are Not Associated With Tumor Response After Neoadjuvant Treatment in Locally Advanced Rectal Cancer

IE Otmani, B Effared, FE Agy, ME Abkari… - Clinical …, 2022 - journals.sagepub.com
In patients with locally advanced rectal cancer, neoadjuvant radiotherapy or
chemoradiotherapy followed by total mesorectal excision as a standard of care. We aimed to …